Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatable dementias.

J L Cummings

    Advances in Neurology
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Dementia involves intellectual decline, which can be reversible. Identifying toxic exposures, metabolic issues, or treatable conditions through careful evaluation is crucial for managing dementia effectively.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders.

    International psychogeriatrics·2025
    Same author

    Dual Task Performance Is Associated with Amyloidosis in Cognitively Healthy Adults.

    The journal of prevention of Alzheimer's disease·2022
    Same author

    Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD).

    The journal of prevention of Alzheimer's disease·2020
    Same author

    TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology.

    The journal of prevention of Alzheimer's disease·2020
    Same author

    The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.

    The journal of prevention of Alzheimer's disease·2020
    Same author

    Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease.

    International journal of clinical practice·2015

    Area of Science:

    • Neurology
    • Geriatrics
    • Toxicology

    Background:

    • Dementia is a syndrome of acquired intellectual deterioration.
    • It can be permanent or reversible, with diverse etiologies.
    • Elderly individuals are particularly susceptible to metabolic influences on cognitive function.

    Purpose of the Study:

    • To outline the diagnostic approach for evaluating dementia.
    • To highlight the importance of identifying treatable causes of dementia.
    • To emphasize the role of history, physical examination, and laboratory tests.

    Main Methods:

    • Detailed patient history focusing on exposures (drugs, metals, toxins).
    • Physical examination to identify neurological deficits (focal deficits, spasticity, ataxia).

    Related Experiment Videos

  • Comprehensive laboratory evaluation including blood tests, imaging (CT), and lumbar puncture.

    • Main Results:

    • Specific symptoms and signs correlate with potential causes (e.g., peripheral neuropathy with toxic/metabolic disorders).
    • EEG and CT findings aid in diagnosing structural lesions and encephalopathies.
    • Laboratory tests can reveal treatable conditions affecting intellectual function.

    Conclusions:

    • A thorough diagnostic workup is essential for all dementia patients.
    • Treatable causes, especially toxic and metabolic disorders, must be actively sought.
    • Early identification and management of reversible factors can improve outcomes.